Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
sabato, ottobre 24
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Globus Medical Inc
GMED
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$81.41
-0.25
-0.31%
Ult. Agg.: Oct 23, 4:00 PM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Utili:
I risultati di Q3 2026 tra 12 giorni da adesso in gio nov 5th, dopo la chiusura del mercato
Globus Medical Financials
Globus Medical (GMED) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Globus Medical Raises FY2026 Adj EPS Guidance from $4.70-$4.80 to $4.95-$5.05 vs $4.74 Est; Affirms FY2026 Sales Guidance of $3.180B-$3.220B vs $3.201B Est
Globus Medical (NYSE:GMED) raises FY2026 Adj EPS guidance from $4.70-$4.80 to $4.95-$5.05 vs $4.74 analyst estimate. Affirms FY2026 sales outlook from $3.180 billion-$3.220 billion to $3.180 billion-$3.220 billion vs
Benzinga Newsdesk
PRO
Globus Medical Q2 Adj. EPS $1.34 Beats $1.10 Estimate, Sales $789.612M Beat $782.840M Estimate
Globus Medical (NYSE:GMED) reported quarterly earnings of $1.34 per share which beat the analyst consensus estimate of $1.10 by 21.82 percent. This is a 55.81 percent increase over earnings of $0.86 per share from the
Benzinga Newsdesk
PRO
Globus Medical Raises FY2026 Adj EPS Guidance from $4.40-$4.50 to $4.70-$4.80 vs $4.47 Est; Affirms FY2026 Sales Guidance of $3.180B-$3.220B vs $3.202B Est
Globus Medical (NYSE:GMED) raises FY2026 Adj EPS guidance from $4.40-$4.50 to $4.70-$4.80 vs $4.47 analyst estimate. Affirms FY2026 sales outlook from $3.180 billion-$3.220 billion to $3.180 billion-$3.220 billion vs
Benzinga Newsdesk
PRO
Globus Medical Q1 Adj. EPS $1.12 Beats $0.92 Estimate, Sales $759.854M Beat $736.999M Estimate
Globus Medical (NYSE:GMED) reported quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $0.92 by 21.74 percent. This is a 64.71 percent increase over earnings of $0.68 per share from the
Benzinga Newsdesk
PRO
Globus Medical Raises FY2026 Adj EPS Guidance from $4.30-$4.40 to $4.40-$4.50 vs $4.26 Est; Affirms FY2026 Sales Guidance of $3.180B-$3.220B vs $3.165B Est
Benzinga Newsdesk
PRO
Globus Medical Q4 Adj. EPS $1.28 Beats $1.15 Estimate, Sales $826.420M Beat $799.123M Estimate
Benzinga Newsdesk
